10 Small Submissions
No more than 10 Documents per submission
Freyr.NEXT is a visionary program that started a few years ago to give tangible Regulatory process benefits for our customers and started evolving with growing requirements from them. We are currently working on many of the use cases that are in various stages of development, strictly for our customer-specific and internal business needs.
Freyr’s Use Case definition is comprised of a combination of specific Product type (Pharmaceutical, Biologics, Medical Devices, Consumer), Market type (Globally divided into multiple market types), Functional stream (Regulatory Strategy, Plan, Preparation, Dossier, Label, Artwork, etc.) and Data sources (External, Internal), Business value (Decision making, Optimization, etc.), Technology (Analytics, RPA, ML, NLP, etc.).
Freyr.NEXT Technological innovation is a substantial lever for innovation in Regulatory transformation as it makes everything possible. Artificial intelligence (AI) including machine learning, intelligent automation extends the substantial scope for transforming or restating processes i.e., not just mirroring what people do, rather turning up innovative ways of accomplishing critical goals.
With respect to the client-specific use cases, our Regulatory affairs specialized engineering team, through its advanced automation, encompasses everything from dossier management, HA query responses, global Labeling management, proof-reading of dossier/Labeling documents and automated artwork generation.
We develop and execute “Intelli Bots” to answer operational and other decision enabling questions using historical and evolving real-time global Regulatory intelligence.
Freyr.NEXT leverages technological advances like RPA, AI, ML, etc. to innovate Regulatory Affairs. We create a strategic plan for automation, where each process in Regulatory Affairs ranging from Regulatory Strategy to Life Cycle maintenance is accessed based on a specific client use case to develop an “Automation workstream” ensuring:
Freyr is uniquely positioned as one of the very few companies in the Life Sciences end-to-end Regulatory solutions and services space, with a thorough understanding of the challenges in AI/ML-based innovations. Our experienced and highly skilled consultants and process expertise have unlocked the science behind self-evolving adaptive algorithms that are designed to learn from real-world experiences in the Life Sciences.
The Primary objective is process improvement and automation, which is enabled by quick, smart solutions with well-defined small digital components such as bots, pdf scripts, Excel, Word, Macros to AI/ML components.
Transformational large scale digital innovation programs - RPA/AI/ML/NLP-based. The potential combination of automation, software platform and people, implementation of automation tools with continuous learning through Artificial Intelligence & Deep-Learning Algorithms.
For integrated Regulatory functional eco system